| Krämer J, Ruf RG, Schmidt S, et al.
The CAIRP (CAndesartan for In-stent Restenosis Prevention) Trial - A Multicenter Study of AT1-Receptor Blocker Therapy in Coronary Stenting. [Journal Article]
J Invasive Cardiol 2008 May; 20(5):205-10.
Abstract | Full Citation | Find Related Articles | | Ottosson P, Attman PO, Agren AC, et al.
Candesartan cilexetil in haemodialysis patients. [Journal Article]
Clin Drug Investig 2003; 23(8):545-50.
Abstract | Full Citation | Find Related Articles | | Kusuyama T, Yoshiyama M, Omura T, et al.
Angiotensin blockade inhibits osteopontin expression in non-infarcted myocardium after myocardial infarction. [Journal Article]
J Pharmacol Sci 2005 Jul; 98(3):283-9.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Malik RA, Schofield IJ, Izzard A, et al.
Effects of angiotensin type-1 receptor antagonism on small artery function in patients with type 2 diabetes mellitus. [Clinical Trial, Journal Article, Randomized Controlled Trial]
Hypertension 2005 Feb; 45(2):264-9.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Matsumoto R, Yoshiyama M, Omura T, et al.
Effects of aldosterone receptor antagonist and angiotensin II type I receptor blocker on cardiac transcriptional factors and mRNA expression in rats with myocardial infarction. [Journal Article]
Circ J 2004 Apr; 68(4):376-82.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Yoshiyama M, Omura T, Takeuchi K, et al.
Angiotensin blockade inhibits increased JNKs, AP-1 and NF- kappa B DNA-binding activities in myocardial infarcted rats. [Journal Article]
J Mol Cell Cardiol 2001 Apr; 33(4):799-810.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Omura T, Yoshiyama M, Ishikura F, et al.
Myocardial ischemia activates the JAK-STAT pathway through angiotensin II signaling in in vivo myocardium of rats. [Journal Article]
J Mol Cell Cardiol 2001 Feb; 33(2):307-16.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Manolis AJ, Grossman E, Jelakovic B, et al.
Effects of losartan and candesartan monotherapy and losartan/hydrochlorothiazide combination therapy in patients with mild to moderate hypertension. Losartan Trial Investigators. [Clinical Trial, Journal Article, Multicenter Study, Randomized Controlled Trial]
Clin Ther 2000 Oct; 22(10):1186-203.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Nesbitt SD, Julius S
Prehypertension: a possible target for antihypertensive medication. [Clinical Trial, Controlled Clinical Trial, Journal Article, Review]
Curr Hypertens Rep 2000 Aug; 2(4):356-61.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Cice G, Ferrara L, Tagliamonte E, et al.
[Angiotensin-II receptor inhibitors in hemodialysed uremia patients with arterial hypertension: candesartan cilexitil versus losartan] [Clinical Trial, Journal Article, Randomized Controlled Trial]
Cardiologia 1999 Dec; 44(12):1071-6.
Abstract | Full Citation | Find Related Articles |   |
|
| | Enter
www.unboundmedicine.com/medline
in your iPhone browser
or View our
Unbound MEDLINE
iPhone demo
Advertise on this site.
|
